Document is current
Any future updates will be listed below
-
Authors
Faltracco, Veronica
Poletti, Barbara
Aiello, Edoardo Nicolò
Telesca, Alessandra
Bella, Eleonora Dalla
Bersano, Enrica
Silani, Vincenzo
Ticozzi, Nicola
Lauria, Giuseppe
Consonni, Monica https://orcid.org/0000-0002-0479-2290
-
Funding
Funding for this research was provided by:
Fondazione Regionale per la Ricerca Biomedica, Regione Lombardia (2015-0023)
Fondo Europeo di Sviluppo Regionale, Regione Lombardia (1157625)
Ministero della Salute (RRC)
- License Information
-
More Information
Article History
Received: 12 February 2024
Accepted: 17 June 2024
First Online: 2 July 2024
Declarations
:
: Methods section includes a statement that an IRB approved the use of human subjects for this study.
: The authors vouch for the accuracy of the manuscript and agree with its content, i.e.: "The study was approved by the local Ethics Committee. All patients provided written informed consent before enrolment."
: V. S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG, Zambon Biotech SA and Amylyx Pharmaceuticals, and receives or has received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is in the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, Frontiers in Neurology and Exploration of Neuroprotective Therapy. B.P. received compensation for consulting services and/or speaking activities from Liquidweb S.r.l B.P is Associate Editor for Frontiers in Neuroscience. N. T. received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is Associate Editor for Frontiers in Aging Neuroscience.
